Psychedelic Bulletin: Delix Raises $70m Series A; Toronto Gets Psychedelics Research Centre; Elon Musk Endorses Psychedelics Post published:October 1, 2021 Post category:Psychedelic Bulletin
Mydecine Completes Spin-Out of U.S. Cannabis Assets Post published:October 1, 2021 Post category:Press Release
MindMed Announces Appointment of Andreas Krebs and Carol Vallone as Directors and Transition of Bruce Linton Post published:September 30, 2021 Post category:Press Release
MINDCURE Announces Commencement of Trading on the OTCQX Best Market Post published:September 30, 2021 Post category:Press Release
PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs Advisor Post published:September 29, 2021 Post category:Press Release
Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates Post published:September 29, 2021 Post category:Press Release
Red Light Holland: Initial Results From Red Light Oregon Market Research in Oregon Show 86% of Adults Interested in Psilocybin Services are Interested in Microdosing Post published:September 29, 2021 Post category:Press Release
MindMed Appoints University of North Carolina Psychiatrist and Pharmacologist Dr. Bryan Roth to Scientific Advisory Board Post published:September 29, 2021 Post category:Press Release
Psyence Group and Pure Extracts Finalize “Pure Psyence,” A Joint Venture for the Development of Psychedelic Medicinal Mushroom Extracts Post published:September 28, 2021 Post category:Press Release
PharmaTher Announces Closing of CAD$10 Million Private Placement with Institutional Investors Post published:September 28, 2021 Post category:Press Release